Serotonin reuptake inhibition: An update on current research strategies

被引:82
作者
Spinks, D [1 ]
Spinks, G [1 ]
机构
[1] Organon Res Labs Ltd, Dept Med Chem, Newhouse ML1 5SH, Lanark, Scotland
关键词
D O I
10.2174/0929867024606795
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Selective Serotonin reuptake inhibitors (SSRIs) have contributed to the major advances in the treatment of depression and other psychiatric diseases, This review summarises current knowledge concerning the SSRI class of drugs and discusses the importance of secondary pharmacology in the mechanism of action and effectiveness of these drugs. Particular attention is given to the emerging importance of the SSRI 'plus' approach: where the serotonin reuptake receptor inhibition of a drug is supplemented by one or more other receptor interactions either by the same drug or by a combination therapy. This area of research has shed light on the pharmacological mechanisms of SSRI therapy and has the therapeutic usefulness of serotonin reuptake inhibition, especially in the area of depression. There are many new emerging SSRI 'plus' drugs, which address the pharmacological and pharmacokinetic issues of current therapies and these, are discussed in detail.
引用
收藏
页码:799 / 810
页数:12
相关论文
共 112 条
[31]  
Evrard DA, 1999, ANNU REP MED CHEM, V34, P1
[32]   Relief of SSRI-induced sexual dysfunction with mirtazapine treatment [J].
Farah, A .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (04) :260-261
[33]  
FEENEY A, 1999, INT J PSYCHIAT CLIN, V3, pS3
[34]  
Feighner JP, 1999, J CLIN PSYCHIAT, V60, P4
[35]  
Feighner JP, 1999, J CLIN PSYCHIAT, V60, P18
[36]   Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression [J].
Feighner, JP ;
Overo, K .
JOURNAL OF CLINICAL PSYCHIATRY, 1999, 60 (12) :824-830
[37]  
Frazer A, 2000, J CLIN PSYCHIAT, V61, P25
[38]   INTERACTION BETWEEN A SELECTIVE 5-HT1A RECEPTOR ANTAGONIST AND AN SSRI IN-VIVO - EFFECTS ON 5-HT CELL FIRING AND EXTRACELLULAR 5-HT [J].
GARTSIDE, SE ;
UMBERS, V ;
HAJOS, M ;
SHARP, T .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 115 (06) :1064-1070
[39]   Selective serotonin reuptake inhibitors in the treatment of affective disorders - III. Tolerability, safety and pharmacoeconomics [J].
Goldstein, BJ ;
Goodnick, PJ .
JOURNAL OF PSYCHOPHARMACOLOGY, 1998, 12 (03) :S55-S87
[40]   Selective serotonin reuptake inhibitors in affective disorders - I. Basic pharmacology [J].
Goodnick, PJ ;
Goldstein, BJ .
JOURNAL OF PSYCHOPHARMACOLOGY, 1998, 12 (03) :S5-S20